MSB 1.86% $1.32 mesoblast limited

Ann: Mesoblast Completes Institutional Allocation, page-52

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 30,389 Posts.
    lightbulb Created with Sketch. 1863
    Please a sense of proportion's needed.

    Who cares about the shorts? Are ALL of the instos playing games with them?

    Surely not. Surely the oversubscribed bit is not hitting enough home, along with the new instos on board.

    Perspective: Market conditions for biotechs is cut-throat right now, it's much tighter than the time of the Nasdaq listing when many new listings failed. We are in an extremely tight environment for raising capital. It's unbelievable how conservative lenders are being.

    MSB goes to market with an offer and gets over-subscribed. What does that tell you?

    Do those analysts have a clue? I think they do.

    Shenanigans involving shorts is a side issue. Yes it affects the SP but LT we should be looking at how the company is stacking up.

    Looking solid to me.
    Last edited by dolcevita: 05/12/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.